Home / 2015 (page 37)

Yearly Archives: 2015

Diagnosing Gastroparesis – Part 7

Diabetes Solution Richard K. Bernstein, MD, FACE, FACN, FACCWS Part 7 Chapter 22 Gastroparesis Exercises That Facilitate Stomach-Emptying The paretic stomach may be described as a flaccid bag, deprived of the rhythmic muscular squeezing present in a stomach that has a properly functioning vagus nerve. Any activity that rhythmically compresses …

Read More »

Modifications of Preprandial or ISA Regimens to Accommodate Gastroparesis – Part 10

Diabetes Solution Richard K. Bernstein, MD, FACE, FACN, FACCWS Part 10 Chapter 22 Gastroparesis Modifications of Preprandial or ISA Regimens to Accommodate Gastroparesis It takes a while for your physician to select and fine-tune a program to improve stomach-emptying. In the meantime, it’s possible to reduce the frequency and severity …

Read More »

Editor’s Note, DCMS #257

The diabetes newsletters and services have all been carrying articles about the artificial pancreas. There are three basic components to the device. There is a pump to deliver insulin and a pump to deliver glucagon, however, the “brains” of the system is the glucose reading device. Without the brains, then …

Read More »

When Assessing Glucose Levels and Treatment, Look for the Patterns

Patient, type 2 diabetes and obesity, on basal/bolus insulin with an A1C of 10.7%. He was not following any particular meal plan, and was, for the most part, consuming a high carb diet. Diabetes education was provided, including how carbohydrates affect glucose levels, lowering his carbs, and ideal target glucose levels. We told him we did not expect him to reach these levels right away, in fact we wanted to see how he adjusted to the change in diet without low glucose levels, so we recommended he decrease both his basal and bolus insulin, with clear instructions on how much insulin to take...

Read More »

George Bakris, MD: SGLT2 Mechanism for BP Reduction Part 6 of 6

alt

This week George Bakris, MD, does some quick math to determine the cost of diabetes as it relates to dialysis and contemplates the future of dialysis equipment. He also shares current dialysis treatment options that may offer some flexibility to patient currently bound to visiting treatment centers....

Read More »

“Synjardy” Approved for Type 2 Diabetes

Single-tablet approach hoped to boost treatment compliance and help patients better manage condition.. Synjardy contains empagliflozin, a sodium-glucose co-transporter 2 (SGLT2) inhibitor, and metformin, a biguanide. It is not for the treatment of type 1 diabetes or diabetic ketoacidosis. The drug label contains a boxed warning on the risk of …

Read More »